Breaking News Instant updates and real-time market news.

AUPH

Aurinia Pharmaceuticals

$6.15

-0.06 (-0.97%)

08:08
06/12/19
06/12
08:08
06/12/19
08:08

Aurinia Pharmaceuticals holder ILJIN urges holders to vote for their nominees

ILJIN, a founding shareholder of Aurinia Pharmaceuticals, which together with certain affiliates holds an approximate 14% ownership interest in Aurinia, filed an investor presentation on SEDAR in connection with the corporation's upcoming Annual General Meeting of Shareholders to be held on Wednesday, June 26. Young-Hwa Kim, CEO of ILJIN, said, "ILJIN has worked quietly behind the scenes for over two years to help Aurinia improve its corporate governance and ultimately realize its tremendous potential. While the incumbent Board has rejected our good faith attempts to engage, Aurinia shareholders now have a choice. The future is in your hands. We urge you to vote your GREEN Proxy or GREEN VIF in favor of a more qualified and independent board, better governance and leadership stability, and a bright future for Aurinia." Shareholders are urged to read the circular and vote ONLY the GREEN proxy or GREEN VIF.

AUPH Aurinia Pharmaceuticals
$6.15

-0.06 (-0.97%)

03/20/19
CANT
03/20/19
NO CHANGE
Target $24
CANT
Overweight
Aurinia Pharmaceuticals price target raised to $24 from $18 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Aurinia Pharmaceuticals to $24 from $18 and reiterates an Overweight rating on the shares following the company's Q4 results. The new target reflects Aurinia's recent Notice of Allowance regarding a U.S. patent related to voclosporin's method of use. The analyst no longer anticipate a decrease in the voclosporin price in 2027 from generic entry. However, the largest driver of Aurinia's shares will likely be a focus on Phase 3 data for voclosporin for the treatment of lupus nephritis, which could be announced by year-end 2019, says Piros.
03/20/19
RBCM
03/20/19
NO CHANGE
Target $11
RBCM
Outperform
Aurinia Pharmaceuticals price target raised to $11 from $9 at RBC Capital
RBC Capital analyst Douglas Miehm raised his price target on Aurinia Pharmaceuticals to $11 and kept his Outperform rating. The analyst says the company's Q4 results contained "no surprises" as it remains on track for its phase 3 lupus nephritis trial, with the readout expected later this year. Miehm adds that his higher price target reflects his updated model for positive voclosporin IP developments.
05/23/19
HCWC
05/23/19
NO CHANGE
Target $25
HCWC
Buy
Aurinia Pharmaceuticals price target raised to $25 from $15 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Aurinia Pharmaceuticals to $25 from $15 and reiterates a Buy rating on the shares.
06/04/19
HCWC
06/04/19
NO CHANGE
Target $25
HCWC
Buy
Aurinia board can defeat proxy challenge, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce noted that Aurinia's largest shareholder, ILJIN SNT Co., announced over the weekend that it has launched a proxy contest to elect at least three directors to the company's eight member board. Arce does not agree with ILJIN's claims of excessive compensation, high operating costs or governance failures and believes the current board and new CEO are "well suited" to commercialize voclosporin to its "full potential," he tells investors. The analyst, who said he is confident the current board can defeat this proxy challenge, keeps a Buy rating and $25 price target on Aurinia shares.

TODAY'S FREE FLY STORIES

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

07:53
06/24/19
06/24
07:53
06/24/19
07:53
Initiation
Concert Pharmaceuticals initiated  »

SunTrust starts Concert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

WAB

Wabtec

$72.75

0.42 (0.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Downgrade
Wabtec rating change  »

Wabtec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHSP

SharpSpring

$12.84

-0.34 (-2.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Upgrade
SharpSpring rating change  »

SharpSpring upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$85.58

2.55 (3.07%)

07:50
06/24/19
06/24
07:50
06/24/19
07:50
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Sep

BARZ

5Barz

$0.00

(0.00%)

07:49
06/24/19
06/24
07:49
06/24/19
07:49
Hot Stocks
5Barz signs agreement with Kaynes Technology for Network Extender in India »

5BARz International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Earnings
LiveRamp raises FY20 revenue view to $363M-$377M from $358M-$372M »

Consensus $366.45M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBIX

Ebix

$47.71

0.48 (1.02%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Hot Stocks
Ebix expands A.D.A.M. Health Services business with client wins »

Ebix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$5.72

-0.07 (-1.21%)

07:46
06/24/19
06/24
07:46
06/24/19
07:46
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
LiveRamp to acquire Data Plus Math »

LiveRamp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Emerald Health receives cultivation license for cannabis operation in BC »

Emerald Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Icahn says 'pleased' with Caesars, Eldorado Resorts planned merger »

Carl Icahn said, …

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

VLRX

Valeritas

$2.85

0.025 (0.88%)

07:43
06/24/19
06/24
07:43
06/24/19
07:43
Hot Stocks
Valeritas sells over 20M V-Go insulin delivery devices in the U.S. »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

, CZR

Caesars

$9.99

-0.05 (-0.50%)

07:42
06/24/19
06/24
07:42
06/24/19
07:42
Conference/Events
Eldorado Resorts to host conference call »

Conference call to…

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

CZR

Caesars

$9.99

-0.05 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

ALO

Alio Gold

$0.72

-0.0004 (-0.06%)

07:42
06/24/19
06/24
07:42
06/24/19
07:42
Hot Stocks
Alio Gold says ISS, Glass Lewis recommend shareholders vote for propsals »

Alio Gold announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$24.17

-1.11 (-4.39%)

07:40
06/24/19
06/24
07:40
06/24/19
07:40
Hot Stocks
Axsome Therapeutics initiates GEMINI Phase 3 trial of AXS-05 »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$50.62

-0.7 (-1.36%)

, APC

Anadarko

$70.37

-0.1 (-0.14%)

07:40
06/24/19
06/24
07:40
06/24/19
07:40
Downgrade
Occidental Petroleum, Anadarko rating change  »

Occidental Petroleum…

OXY

Occidental Petroleum

$50.62

-0.7 (-1.36%)

APC

Anadarko

$70.37

-0.1 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

BAESY

BAE Systems

$0.00

(0.00%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Hot Stocks
BAE Systems awarded $90M Navy contract for C5ISR systems »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$8.67

-0.83 (-8.74%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Hot Stocks
Applied Therapeutics initiates Phase 1/2 sstudy of AT-007 »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NERV

Minerva

$4.23

0.03 (0.71%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Conference/Events
Minerva to hold a conference call »

Chairman & CEO, Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$80.73

-1.715 (-2.08%)

, CIR

Circor

$45.80

-0.19 (-0.41%)

07:38
06/24/19
06/24
07:38
06/24/19
07:38
Hot Stocks
Circor rejects unsolicited tender offer from Crane »

Circor (CIR) announced…

CR

Crane

$80.73

-1.715 (-2.08%)

CIR

Circor

$45.80

-0.19 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

BWAY

Brainsway

$10.09

-0.16 (-1.56%)

07:38
06/24/19
06/24
07:38
06/24/19
07:38
Hot Stocks
Brainsway announces shipment of 100th Deep TMS helmet for treatment of OCD »

BrainsWay announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLNE

Hamilton Lane

$56.76

0.29 (0.51%)

07:36
06/24/19
06/24
07:36
06/24/19
07:36
Hot Stocks
Hamilton Lane closes latest co-investment fund above target »

Hamilton Lane announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:35
06/24/19
06/24
07:35
06/24/19
07:35
General news
U.S. equities are modestly higher »

U.S. equities are…

DFRG

Del Frisco's

$6.73

-0.18 (-2.60%)

07:34
06/24/19
06/24
07:34
06/24/19
07:34
Hot Stocks
Del Frisco's to be acquired by L Catterton for approx. $650M »

Del Frisco's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Nov

DE

Deere

$164.29

1.49 (0.92%)

07:34
06/24/19
06/24
07:34
06/24/19
07:34
Upgrade
Deere rating change  »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 17

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.